• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cardiac resynchronization therapy improves altered Na channel gating in canine model of dyssynchronous heart failure.心脏再同步治疗改善犬非同步性心力衰竭模型中改变的钠通道门控。
Circ Arrhythm Electrophysiol. 2013 Jun;6(3):546-54. doi: 10.1161/CIRCEP.113.000400. Epub 2013 May 6.
2
Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy.不同步心力衰竭的电生理后果及其通过再同步治疗的恢复
Circulation. 2009 Mar 10;119(9):1220-30. doi: 10.1161/CIRCULATIONAHA.108.794834. Epub 2009 Feb 23.
3
Electrical remodeling in dyssynchrony and resynchronization.电重构在不同步和再同步中的作用。
J Cardiovasc Transl Res. 2012 Apr;5(2):170-9. doi: 10.1007/s12265-012-9348-9. Epub 2012 Jan 21.
4
Electrical remodeling in the failing heart.衰竭心脏中的电重构。
Curr Opin Cardiol. 2010 Jan;25(1):29-36. doi: 10.1097/HCO.0b013e328333d3d6.
5
Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization.心脏再同步化治疗逆转整体细胞凋亡和局部应激激酶激活。
Circulation. 2008 Mar 18;117(11):1369-77. doi: 10.1161/CIRCULATIONAHA.107.706291. Epub 2008 Mar 3.
6
Cardiac Resynchronization Therapy Reduces Subcellular Heterogeneity of Ryanodine Receptors, T-Tubules, and Ca2+ Sparks Produced by Dyssynchronous Heart Failure.心脏再同步治疗可减少由不同步心力衰竭产生的兰尼碱受体、横管和Ca2+火花的亚细胞异质性。
Circ Heart Fail. 2015 Nov;8(6):1105-14. doi: 10.1161/CIRCHEARTFAILURE.115.002352. Epub 2015 Aug 20.
7
Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy.心脏再同步治疗增强β-肾上腺素能储备的机制。
Circulation. 2009 Mar 10;119(9):1231-40. doi: 10.1161/CIRCULATIONAHA.108.774752. Epub 2009 Feb 23.
8
Comparative electromechanical and hemodynamic effects of left ventricular and biventricular pacing in dyssynchronous heart failure: electrical resynchronization versus left-right ventricular interaction.比较左心室和双心室起搏在不同步性心力衰竭中的机电和血液动力学效应:电再同步与左右心室相互作用。
J Am Coll Cardiol. 2013 Dec 24;62(25):2395-2403. doi: 10.1016/j.jacc.2013.08.715. Epub 2013 Sep 4.
9
Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level.心脏再同步治疗可在基因组水平上纠正由不同步引起的区域基因表达变化。
Circ Cardiovasc Genet. 2009 Aug;2(4):371-8. doi: 10.1161/CIRCGENETICS.108.832345. Epub 2009 May 15.
10
Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling.心脏再同步治疗通过胆碱能信号的差异性重塑恢复衰竭心脏的交感迷走神经平衡。
Circ Res. 2015 May 8;116(10):1691-9. doi: 10.1161/CIRCRESAHA.116.305268. Epub 2015 Mar 2.

引用本文的文献

1
New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models.新型抗心律失常药物的发现:动物模型的研究进展。
Sci Rep. 2023 Sep 29;13(1):16420. doi: 10.1038/s41598-023-41942-4.
2
Animal Models to Study Cardiac Arrhythmias.研究心脏心律失常的动物模型。
Circ Res. 2022 Jun 10;130(12):1926-1964. doi: 10.1161/CIRCRESAHA.122.320258. Epub 2022 Jun 9.
3
Proteomic and functional mapping of cardiac NaV1.5 channel phosphorylation sites.心脏 NaV1.5 通道磷酸化位点的蛋白质组学和功能图谱。
J Gen Physiol. 2021 Feb 1;153(2). doi: 10.1085/jgp.202012646.
4
Cardiac resynchronization therapy reduces expression of inflammation-promoting genes related to interleukin-1β in heart failure.心脏再同步治疗可降低心力衰竭中与白细胞介素-1β相关的促炎基因的表达。
Cardiovasc Res. 2020 Jun 1;116(7):1311-1322. doi: 10.1093/cvr/cvz232.
5
Rationale and design of the IRON-CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy.IRON-CRT 试验的原理和设计:静脉注射羧基麦芽糖铁对心脏再同步治疗后逆向重构的影响。
ESC Heart Fail. 2019 Dec;6(6):1208-1215. doi: 10.1002/ehf2.12503. Epub 2019 Sep 28.
6
The mechanical effects of CRT promoting autophagy via mitochondrial calcium uniporter down-regulation and mitochondrial dynamics alteration.CRT 通过下调线粒体钙单向转运蛋白和改变线粒体动力学促进自噬的机械作用。
J Cell Mol Med. 2019 Jun;23(6):3833-3842. doi: 10.1111/jcmm.14227. Epub 2019 Apr 2.
7
C-terminal phosphorylation of Na1.5 impairs FGF13-dependent regulation of channel inactivation.钠通道蛋白1.5(Na1.5)的C末端磷酸化会损害成纤维细胞生长因子13(FGF13)依赖的通道失活调节。
J Biol Chem. 2017 Oct 20;292(42):17431-17448. doi: 10.1074/jbc.M117.787788. Epub 2017 Sep 7.
8
Inhibition of serum and glucocorticoid regulated kinase-1 as novel therapy for cardiac arrhythmia disorders.抑制血清和糖皮质激素调节激酶-1 作为治疗心律失常疾病的新策略。
Sci Rep. 2017 Mar 23;7(1):346. doi: 10.1038/s41598-017-00413-3.
9
Myocyte repolarization modulates myocardial function in aging dogs.心肌复极化调节衰老犬的心肌功能。
Am J Physiol Heart Circ Physiol. 2016 Apr 1;310(7):H873-90. doi: 10.1152/ajpheart.00682.2015. Epub 2016 Jan 22.
10
Cellular and Molecular Aspects of Dyssynchrony and Resynchronization.不同步与再同步的细胞和分子层面
Card Electrophysiol Clin. 2015 Dec;7(4):585-97. doi: 10.1016/j.ccep.2015.08.011.

本文引用的文献

1
Reactive oxygen species-activated Ca/calmodulin kinase IIδ is required for late I(Na) augmentation leading to cellular Na and Ca overload.活性氧诱导的 Ca/钙调蛋白激酶 IIδ 对于晚期 I(Na)增强导致细胞内 Na 和 Ca 过载是必需的。
Circ Res. 2011 Mar 4;108(5):555-65. doi: 10.1161/CIRCRESAHA.110.221911. Epub 2011 Jan 20.
2
Inhibition of elevated Ca2+/calmodulin-dependent protein kinase II improves contractility in human failing myocardium.抑制钙/钙调蛋白依赖性蛋白激酶 II 的升高可改善人心力衰竭时的收缩性能。
Circ Res. 2010 Oct 29;107(9):1150-61. doi: 10.1161/CIRCRESAHA.110.220418. Epub 2010 Sep 2.
3
Elevated cytosolic Na+ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes.细胞溶质中钠离子浓度的升高会增加衰竭心肌细胞中线粒体活性氧的形成。
Circulation. 2010 Apr 13;121(14):1606-13. doi: 10.1161/CIRCULATIONAHA.109.914911. Epub 2010 Mar 29.
4
Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts.双心室起搏对不同步衰竭心脏线粒体蛋白质组的调节及线粒体功能的改善
Circ Cardiovasc Genet. 2010 Feb;3(1):78-87. doi: 10.1161/CIRCGENETICS.109.871236. Epub 2009 Nov 17.
5
Effect of right ventricular versus biventricular pacing on electrical remodeling in the normal heart.右心室与双心室起搏对正常心脏电重构的影响。
Circ Arrhythm Electrophysiol. 2010 Feb;3(1):79-87. doi: 10.1161/CIRCEP.109.889741. Epub 2009 Dec 30.
6
Na+ channel regulation by Ca2+/calmodulin and Ca2+/calmodulin-dependent protein kinase II in guinea-pig ventricular myocytes.豚鼠心室肌细胞中Ca2+/钙调蛋白和Ca2+/钙调蛋白依赖性蛋白激酶II对Na+通道的调节
Cardiovasc Res. 2010 Feb 1;85(3):454-63. doi: 10.1093/cvr/cvp324. Epub 2009 Oct 1.
7
Increased late sodium currents are related to transcription of neuronal isoforms in a pressure-overload model.在压力超负荷模型中,晚期钠电流的增加与神经元亚型的转录有关。
Eur J Heart Fail. 2009 Aug;11(8):749-57. doi: 10.1093/eurjhf/hfp092. Epub 2009 Jul 7.
8
Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy.不同步心力衰竭的电生理后果及其通过再同步治疗的恢复
Circulation. 2009 Mar 10;119(9):1220-30. doi: 10.1161/CIRCULATIONAHA.108.794834. Epub 2009 Feb 23.
9
Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling.氧化应激诱导的后去极化与钙调蛋白激酶II信号传导
Circ Res. 2009 Jan 2;104(1):79-86. doi: 10.1161/CIRCRESAHA.108.183475. Epub 2008 Nov 26.
10
Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization.心脏再同步化治疗逆转整体细胞凋亡和局部应激激酶激活。
Circulation. 2008 Mar 18;117(11):1369-77. doi: 10.1161/CIRCULATIONAHA.107.706291. Epub 2008 Mar 3.

心脏再同步治疗改善犬非同步性心力衰竭模型中改变的钠通道门控。

Cardiac resynchronization therapy improves altered Na channel gating in canine model of dyssynchronous heart failure.

机构信息

Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

出版信息

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):546-54. doi: 10.1161/CIRCEP.113.000400. Epub 2013 May 6.

DOI:10.1161/CIRCEP.113.000400
PMID:23650309
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4114055/
Abstract

BACKGROUND

Slowed Na⁺ current (INa) decay and enhanced late INa (INa-L) prolong the action potential duration (APD) and contribute to early afterdepolarizations. Cardiac resynchronization therapy (CRT) shortens APD compared with dyssynchronous heart failure (DHF); however, the role of altered Na⁺ channel gating in CRT remains unexplored.

METHODS AND RESULTS

Adult dogs underwent left-bundle branch ablation and right atrial pacing (200 beats/min) for 6 weeks (DHF) or 3 weeks followed by 3 weeks of biventricular pacing at the same rate (CRT). INa and INa-L were measured in left ventricular myocytes from nonfailing, DHF, and CRT dogs. DHF shifted voltage-dependence of INa availability by -3 mV compared with nonfailing, enhanced intermediate inactivation, and slowed recovery from inactivation. CRT reversed the DHF-induced voltage shift of availability, partially reversed enhanced intermediate inactivation but did not affect DHF-induced slowed recovery. DHF markedly increased INa-L compared with nonfailing. CRT dramatically reduced DHF-induced enhanced INa-L, abbreviated the APD, and suppressed early afterdepolarizations. CRT was associated with a global reduction in phosphorylated Ca²⁺/Calmodulin protein kinase II, which has distinct effects on inactivation of cardiac Na⁺ channels. In a canine AP model, alterations of INa-L are sufficient to reproduce the effects on APD observed in DHF and CRT myocytes.

CONCLUSIONS

CRT improves DHF-induced alterations of Na⁺ channel function, especially suppression of INa-L, thus, abbreviating the APD and reducing the frequency of early afterdepolarizations. Changes in the levels of phosphorylated Ca²⁺/Calmodulin protein kinase II suggest a molecular pathway for regulation of INa by biventricular pacing of the failing heart.

摘要

背景

钠电流(INa)衰减减慢和晚期 INa(INa-L)增强会延长动作电位时程(APD),并导致早期后除极。心脏再同步治疗(CRT)可缩短 APD,与不同步性心力衰竭(DHF)相比;然而,改变的钠通道门控在 CRT 中的作用仍未得到探索。

方法和结果

成年犬接受左束支消融和右心房起搏(200 次/分)6 周(DHF)或 3 周,然后以相同的速率进行双心室起搏 3 周。从非衰竭、DHF 和 CRT 犬的左心室心肌细胞中测量 INa 和 INa-L。与非衰竭相比,DHF 使 INa 可用性的电压依赖性向负 3 mV 移位,增强了中间失活,并减慢了失活的恢复。CRT 逆转了 DHF 引起的可用性电压移位,部分逆转了增强的中间失活,但不影响 DHF 引起的失活恢复减慢。DHF 与非衰竭相比明显增加了 INa-L。CRT 显著降低了 DHF 引起的增强的 INa-L,缩短了 APD,并抑制了早期后除极。CRT 与磷酸化钙调蛋白蛋白激酶 II 的整体减少有关,该蛋白激酶 II 对心脏钠通道的失活具有独特的影响。在犬的 AP 模型中,INa-L 的改变足以重现 DHF 和 CRT 心肌细胞中观察到的对 APD 的影响。

结论

CRT 改善了 DHF 引起的钠通道功能改变,特别是抑制 INa-L,从而缩短 APD 并减少早期后除极的频率。磷酸化钙调蛋白蛋白激酶 II 水平的变化表明了调节衰竭心脏双心室起搏时 INa 的分子途径。